← Back to Home

Circulatory Failure: Bringing Advanced Physiology to Clinical Practice

Over 50% of patients with shock do not survive. Circulatory failure is the main cause of multi-organ failure and death. Continuous blood pressure monitoring cannot detect early circulatory collapse when interventions are most effective.

CLINICAL CONSENSUS REFERENCE · EUROPEAN HEART JOURNAL: ACUTE CARDIOVASCULAR CARE (2026) 15, 634–648

Criteria for the Diagnosis of Cardiogenic Shock — European Perspective: A Clinical Consensus Statement of the ACVC, HFA, and EAPCI of the ESC

Hoong Sern Lim, Agnieszka Tycinska, Clement Delmas, Jacob Eifer Møller, Janine Pöss, Christian Stoppe, Christophe Vandenbriele, Holger Thiele, Kurt Huber, Ingo Ahrens, Christian Hassager, Ovidiu Chioncel, Marco Metra, Matteo Pagnesi, Wiktor Kuliczkowski, Maja Cikes, Linda W. van Laake, Alessandro Sionis, Mario Iannaccone, Stephane Manzo-Silberman, Federico Pappalardo, Susanna Price, Thomas F. Lüscher, Benedikt Schrage.
European Heart Journal: Acute CardioVascular Care (2026) 15, 634–648. DOI: 10.1093/ehjacc/zuag100.

Pivotal Physiological Principles from the Consensus Statement

  • The Single-Value Fallacy: “The dilemma of whether to use SBP or MAP for the diagnosis of CS cannot be reconciled, due to the inherent physiologic limitations of arterial BP as a parameter... These limitations simply reflect the fact that the complexities of circulatory shock cannot be captured by a single parameter and certainly not by a single value. Therefore, arterial BP, be it SBP or MAP, must be interpreted in conjunction with other hemodynamic parameters and evidence of hypoperfusion.” (p. 641)
  • Normotensive Shock & Occult Hypoperfusion: Preserved systolic blood pressure resulting from compensatory vasoconstriction (high systemic vascular resistance) is associated with severe organ hypoperfusion and short-term mortality comparable to patients with hypotensive shock.
  • The Three Essential Pillars: Shock diagnosis requires (i) resting end-organ hypoperfusion, (ii) primarily caused by hemodynamic abnormalities, and (iii) underlying cardiac dysfunction commensurate with shock.
  • Mandatory Right-Heart Assessment: Concomitant right heart dysfunction significantly worsens prognosis; central venous filling pressures, CVP waveforms, and right ventricular-arterial coupling must be evaluated.

The Inherent Limitations of Blood Pressure Monitoring

Continuous blood pressure monitoring is routinely used in critical care, cardiac intensive care units, and high-risk operative environments to detect circulatory failure and guide timely, effective interventions. However, there are inherent physiological limitations to relying solely on blood pressure:

1. Low Blood Pressure is a Late Marker of Shock

Compensatory physiological mechanisms vigorously "defend" systemic arterial blood pressure at the expense of regional and microvascular perfusion. For example, the Advanced Trauma Life Support (ATLS) guidelines of the American College of Surgeons have long emphasized that a measurable decrease in blood pressure is expected to occur only when blood volume loss exceeds >30–40% (>1,500 mL in a 70-kg adult), when tissue perfusion is already severely compromised.

2. Blood Pressure Does Not Reveal the Etiology

Blood pressure monitoring does not tell us why the blood pressure is low or how to correct it. Blood pressure is tightly regulated by multiple complex mechanisms with feedback loops. Failure of any of these mechanisms—diminished myocardial contractility, arterial vasoplegia, loss of aortic compliance, or right-heart failure—can result in circulatory collapse. Continuous monitoring of pressure numbers alone cannot provide insight into the underlying mechanism, and by extension cannot guide targeted therapeutic correction.

The premise for conventional blood pressure monitoring is flawed: it cannot detect early circulatory failure when corrective interventions are most effective, and cannot guide appropriate, differentiated therapy to prevent multi-organ failure and death.

Data-Driven, Physiology-Guided Actionable Insights

There is an urgent clinical need for a hemodynamic monitoring system that can detect early signs of circulatory failure and guide appropriate, effective therapy tailored to the patient's individual physiology.

Our aim: To translate advanced physiological concepts directly into the clinical domain, combining these concepts with machine learning to provide a differentiated, precise assessment of the cardiovascular system for personalized therapeutic interventions.

Kymometrics: Beyond the Numbers. Into the Physiology.

Turning Hemodynamic Data into Physiological Insight

← Return to Main Platform Explore Advanced Hemodynamics → Launch CVP Explorer →